NGNE Neurogene Inc. logo

NGNE Neurogene Inc.

Healthcare
$27.10-2.20%ClosedMarket Cap: $428.2M

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

94

13F Shares

16,506,555

Ownership %

78.0%

New Positions

14

Increased Positions

38

Closed Positions

9

Reduced Positions

30

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBCVirtus Biotech Clinical Trials ETF13,0330.76%
SBIOALPS Medical Breakthroughs ETF12,6060.21%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF101,0750.09%
VFMO35,4950.06%
IWCiShares Micro-Cap ETF28,4250.05%
IJE28,4250.05%
FESMFidelity Enhanced Small Cap ETF77,8490.04%
NAJ96,4380.02%
IBBiShares Biotechnology ETF94,6940.02%
AVSCAvantis U.S. Small Cap Equity ETF17,5310.02%
IWNiShares Russell 2000 Value ETF96,4380.02%
NJM270,4610.01%
IWMiShares Russell 2000 ETF270,4610.01%
VTWO48,5040.01%
VEXAX115,8610.00%
VXF115,8610.00%
VIEIX115,8610.00%
VEMPX115,8610.00%
VTIVanguard Total Stock Market ETF382,1910.00%
VITSX382,1910.00%